Literature DB >> 20074007

Evaluation of short- and long-term complications after endoscopically assisted gastropexy in dogs.

Mauricio Dujowich1, Mattew E Keller, S Brent Reimer.   

Abstract

OBJECTIVE: To determine short- and long-term complications in clinically normal dogs after endoscopically assisted gastropexy.
DESIGN: Prospective case series. ANIMALS: 24 dogs. PROCEDURES: Endoscopically assisted gastropexy was performed on each dog. Dogs were evaluated laparoscopically at 1 or 6 months after surgery to assess integrity of the gastropexy. Long-term outcome was determined via telephone conversations conducted with owners > or = 1 year after surgery.
RESULTS: Mean +/- SD gastropexy length was 4.5 +/- 0.9 cm, and mean duration of surgery was 22 +/- 5 minutes. One dog had a partially rotated stomach at the time of insufflation, which was corrected by untwisting the stomach with Babcock forceps. Two dogs vomited within 4 weeks after surgery, but the vomiting resolved in both dogs. Four dogs had diarrhea within 4 weeks after surgery, which resolved without medical intervention. In all dogs, the gastropexy site was firmly adhered to the abdominal wall at the level of the pyloric antrum. Long-term follow-up information was available for 23 dogs, none of which had any episodes of gastric dilatation-volvulus a mean of 1.4 years after gastropexy. CONCLUSIONS AND CLINICAL RELEVANCE: Endoscopically assisted gastropexy can be a simple, fast, safe, and reliable method for performing prophylactic gastropexy in dogs. At 1 and 6 months after gastropexy, adequate placement and adhesion of the gastropexy site to the body wall was confirmed. Such a procedure could maximize the benefits of minimally invasive surgery, such as decreases in morbidity rate and anesthetic time. This technique appeared to be suitable as an alternative to laparoscopic-assisted gastropexy.

Entities:  

Mesh:

Year:  2010        PMID: 20074007     DOI: 10.2460/javma.236.2.177

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Gastric malpositioning and chronic, intermittent vomiting following prophylactic gastropexy in a 20-month-old great Dane dog.

Authors:  Jessie S Sutton; Michele A Steffey; Cecily M Bonadio; Stanley L Marks
Journal:  Can Vet J       Date:  2015-10       Impact factor: 1.008

2.  Occurrence and recurrence of gastric dilatation with or without volvulus after incisional gastropexy.

Authors:  John F Przywara; Steven B Abel; John T Peacock; Susan Shott
Journal:  Can Vet J       Date:  2014-10       Impact factor: 1.008

3.  The superiority of paracostal endoscopic-assisted gastropexy over open incisional and belt loop gastropexy in dogs: a comparison of three prophylactic techniques.

Authors:  A Tavakoli; M Mahmoodifard; A H Razavifard
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

4.  Gastric dilatation and volvulus in a 5-month-old Bernese mountain dog.

Authors:  Meike Hammer; Jean-Guillaume Grand
Journal:  Can Vet J       Date:  2019-06       Impact factor: 1.008

5.  Comparison of perioperative and short-term postoperative complications of gastrointestinal biopsies via laparoscopic-assisted technique versus laparotomy.

Authors:  Laura Mitterman; Jennifer Bonczynski; Kendra Hearon; Laura E Selmic
Journal:  Can Vet J       Date:  2016-04       Impact factor: 1.008

6.  Combined laparoscopic ovariectomy and laparoscopic-assisted gastropexy versus combined laparoscopic ovariectomy and total laparoscopic gastropexy: A comparison of surgical time, complications and postoperative pain in dogs.

Authors:  Fabio Leonardi; Roberto Properzi; Jessica Rosa; Paolo Boschi; Silvia Paviolo; Giovanna L Costa; Cristiano Bendinelli
Journal:  Vet Med Sci       Date:  2020-02-03

7.  Influence of 2 Veress needles and 4 insertion sites on Veress needle penetration depth: A comparative study in cadaveric dogs.

Authors:  Katharina Leschnik; Barbara Bockstahler; Nikola Katic; Johannes P Schramel; Gilles Dupré
Journal:  Vet Surg       Date:  2018-09-23       Impact factor: 1.495

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.